M. Gil

VAV3 mediates resistance to breast cancer endocrine therapy

F. Climent, Yusuke Nakamura, M. Esteller, 2014, Breast Cancer Research.

Expression of endoplasmic reticulum stress proteins is a candidate marker of brain metastasis in both ErbB-2+ and ErbB-2- primary breast tumors.

M. J. van de Vijver, R. Sanz-Pamplona, V. Moreno, 2011, The American journal of pathology.

Patients with Breast Cancer and Negative Sentinel Lymph Node Biopsy without Additional Axillary Lymph Node Dissection: A Follow-Up Study of up to 5 Years

M. Gil, M. J. Plá, J. Martín-Comín, 2007, Oncology.

FN 14 and GRP 94 expression are prognostic / predictive biomarkers of brain metastasis outcome that open up new therapeutic strategies

E. Guney, V. Moreno, B. Oliva, 2016 .

FN14 and GRP94 expression are prognostic/predictive biomarkers of brain metastasis outcome that open up new therapeutic strategies

E. Guney, V. Moreno, B. Oliva, 2015, Oncotarget.

Subdermal re-injection: a method to increase surgical detection of the sentinel node in breast cancer without increasing the false-negative rate

M. Gil, M. J. Plá, J. Martín-Comín, 2006, European Journal of Nuclear Medicine and Molecular Imaging.

Contribution of cytogenetics and in situ hybridization to the study of monoclonal gammopathies of undetermined significance.

F. Solé, B. Espinet, L. Florensa, 2002, Cancer genetics and cytogenetics.

Digital quantification of KI-67 in breast cancer

A. Petit, X. Matías-Guiu, M. Gil, 2018, Virchows Archiv.

Phase II trial of temozolomide for leptomeningeal metastases in patients with solid tumors

C. Balañà, J. Bruna, M. Gil, 2012, Journal of Neuro-Oncology.

Lymphangioleiomyomatosis Biomarkers Linked to Lung Metastatic Potential and Cell Stemness

F. Climent, M. Esteller, J. Serra-Musach, 2015, PloS one.

SEOM guideline for the treatment of malignant glioma

C. Balañà, O. Gallego, M. Gil, 2012, Clinical and Translational Oncology.

Bevacizumab plus irinotecan in recurrent malignant glioma shows high overall survival in a multicenter retrospective pooled series of the Spanish Neuro-Oncology Research Group (GEINO)

C. Balañà, M. Martínez-García, R. Andrés, 2012, Anti-cancer drugs.

Sunitinib administered prior to radiotherapy in patients with non-resectable glioblastoma: results of a Phase II study

C. Balañà, O. Gallego, J. Capellades, 2014, Targeted Oncology.

Trends in the surgical procedures of women with incident breast cancer in Catalonia, Spain, over a 7-year period (2005–2011)

J. Borrás, J. Ribes, M. Gil, 2014, BMC Research Notes.

Predictive factors for omitting lymphadenectomy in patients with node‐positive breast cancer treated with neo‐adjuvant systemic therapy

T. Soler, P. Verdaguer, M. Gil, 2020, The breast journal.

NEURO/MEDICAL ONCOLOGY

Scott N. Hwang, Katrina H. Smith, Susan M. Chang, 2013 .

What are the preoperative factors that can determine the presence of metastases in other axillary nodes in breast cancer when the sentinel node is positive?

I. Catalá, A. García, M. Gil, 2009, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....